⌘K

Home/Filings/4/0001171843-14-005184

4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-14-005184

$ANIKCIK 0000898437operating

View on SEC.gov Company Profile

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 4:59 PM ET

Size

5.5 KB

Accession

0001171843-14-005184

Insider Transaction Report

Form 4

Period: 2014-10-30

Anika Therapeutics, Inc.ANIK

Chief Tech. & Strategy Officer

Transactions

Award
Stock Option (right to buy)
2014-10-30+40,000→ 40,000 total
Exercise: $41.15Exp: 2024-10-30→ Common on Stock (40,000 underlying)

Footnotes (1)

[F1]The stock options vest in four equal installments annually beginning October 30, 2015.

Documents

1 file

4
gff4_ahn110314.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000898437

Filing Metadata

Form type: 4
Filed: Nov 2, 7:00 PM ET
Accepted: Nov 3, 4:59 PM ET
Size: 5.5 KB

View on SEC.gov